Grupo de Bioestatística e Ciencia de Datos Biomédicos
GRID-BDS
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (2)
2021
-
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274
2016
-
Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 308-315